Posts Record Q4 Revenue, FY26 PAT Jumps 31%
Anthem Biosciences Limited · ANTHEM · NSE ·
<b>FY26 Performance:</b> Revenue grew 15.2% to ₹21,243 Mn, while Profit After Tax (PAT) surged 31.1% to ₹5,918 Mn. <b>Record Quarter:</b> Q4FY26 was the "highest revenue quarter ever," with revenue up 26.4% and PAT soaring 129.8% year-over-year. <b>CRDMO Drives Growth:</b> The co…